Evaxion A/S

EVAXNasdaq Denmark Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$28.959 M

$3.21 -1.83%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

417,010,756

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#137Quince TherapeuticsQNCX$31.5M
#138Cel SciCVM$29.4M
#139Evaxion A/SEVAX$29.0M
#140Estrella ImmunopharmaESLA$21.8M
#141TScan TherapeuticsTCRX$21.0M

What if Evaxion A/S were worth as much as…

Open the what-if tool →

Gold $30.3T

$3,355,774

Per share 1,045,412× higher

Bitcoin $1.72T

$190,634.26

Per share 59,388× higher

Nvidia $5.48T

$607,423.20

Per share 189,228× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Evaxion A/S are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.